Viewing Study NCT06726369


Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2025-12-25 @ 8:33 PM
Study NCT ID: NCT06726369
Status: RECRUITING
Last Update Posted: 2025-03-13
First Post: 2024-12-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module